Akums Drugs and Pharmaceuticals Limited
ListedMainboardHealthcare · NSE / BSE
Established in 2004, Akums Drugs and Pharmaceuticals Limited is a leading pharmaceutical CDMO providing end-to-end solutions in product development, manufacturing, R&D, regulatory dossier preparation, and testing for domestic and international markets. The company manufactures and sells branded drugs and APIs, with a diverse portfolio that includes tablets, capsules, liquids, injectables, eye drops, topicals, and even gummy bears. Akums has commercialized 4,025 formulations across more than 60 dosage forms and served 26 of India’s top 30 pharmaceutical companies by revenue in FY 2023. With 10 manufacturing units offering a combined annual capacity of 49.21 billion units and plans to commission two more by FY 2025, the company continues to scale its operations. Many of its facilities are accredited by global regulatory authorities such as EU-GMP, WHO-GMP, and US NSF. As of September 30, 2023, Akums employed 16,463 personnel, including 7,211 full-time and 9,252 contract staff.
Price Band
₹646 – ₹679
Issue Size
₹1857 Cr
Lot Size
22 shares
GMP
₹43
+6.3%
Est. Listing
₹722
at current GMP
Subscribed
63.56x
overall
Open
30 Jul 2024
Close
1 Aug 2024
Allotment
2 Aug 2024
Refund
3 Aug 2024
Demat Credit
4 Aug 2024
Listing
6 Aug 2024
Last updated 12 days ago
Official Registrar Verification
Akums Drugs and Pharmaceuticals Limited Allotment Status
Designated Registrar: Link Intime India Private Limited
Allotment Date
2 Aug 2024
Basis finalization
Refunds Initiate
3 Aug 2024
Mandate release
Demat Credit
4 Aug 2024
Shares in demat
Listing Debut
6 Aug 2024
Trading begins
How to Check Akums Drugs and Pharmaceuticals Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Link Intime India Private Limited's allotment portal.
- Select Akums Drugs and Pharmaceuticals Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Akums Drugs and Pharmaceuticals Limited Public Issue & Market Profile
Akums Drugs and Pharmaceuticals Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹1,856.74 Crores. The shares are offered at a price band of ₹646 to ₹679 per equity share on NSE and BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Public Issue & Allotment Procedure:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 22 shares (approx. ₹14,938 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Official Allotment Timelines & Registrar Guidance:
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2024-08-04, while un-allotted funds or UPI block mandates will be released on 2024-08-03.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.